Trial Profile
A retrospective trial to assess early tumour shrinkage with gimeracil/oteracil/tegafur in combination with cisplatin, versus capecitabine in combination with cisplatin, in patients with advanced, or recurrent, gastric cancer which has not previously been treated with chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Capecitabine; Cisplatin
- Indications Gastric cancer
- Focus Therapeutic Use
- 09 Aug 2015 New trial record